Alpha Tau Medical
Tel Aviv
About Alpha Tau Medical
Alpha Tau Medical is an Israeli medical device company that focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Since then, numerous preclinical trials have found the technology to be effective and safe for various indications and anatomic areas. The findings were published in 12 papers in peer-reviewed scientific journals. Today, the company is running its first clinical trial with very promising preliminary results.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $188.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Apr 2025)
- Ticker: nasdaq:DRTS
- Website: alphatau.com
- Phone: +972-3-618-2477
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/alpha-tau-medical-55321 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.